Preparing
17 results
Applied filters
Mitigating the risks of manipulating injectable medicines
10 February 2026Identified patient-safety risks associated with manipulation must be mitigated as far as reasonably possible.
Risk factors: manipulation of injectable medicines
10 February 2026Key factors to be considered when assessing potential patient-safety risks of aseptic manipulation of injections.
Assessing risks when reconstituting injectable medicines
10 February 2026Assess risks of error and contamination when choosing the appropriate location for aseptic manipulation of injectable medicines.
Understanding and managing the risks associated with handling monoclonal antibodies (mAb)
29 January 2026A systematic approach to occupational risk assessment informs decisions about safe working practices with monoclonal antibodies (mAb)
Supervision of aseptic preparation under Section 10 exemption
17 November 2025The section 10 exemption from the Medicines Act permits aseptic preparation of medicines under the supervision of a pharmacist.
Occupational exposure to monoclonal antibodies
22 October 2025Understanding potential exposure to monoclonal antibodies (mAb) informs the occupational risk assessment
Safe handling of monoclonal antibodies
27 June 2025Considerations for occupational safety when preparing monoclonal antibodies (mAb)
Choosing between fidaxomicin options
18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.
Choosing between oral vancomycin options
18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.
Managing the risks of using effervescent tablets in children
17 April 2025Careful use of effervescent or soluble tablets to deliver part tablet doses for children and neonates can minimise risks of toxicity or suboptimal therapy.